Economic Model for Cost Containment: Evaluating the Utilization of a Touch-Free Zinc Oxide in an Acute Care Hospital

BACKGROUND: Incontinence-associated dermatitis (IAD) is a major concern with hospitalized patients and puts them at higher risk for skin breakdown and ulceration. Zinc oxide has been proven to prevent and treat IAD. Hospitals are constantly looking for ways to provide quality care and be fiscally responsible. Hospital caregivers apply ointments with gloved hand directly to area of concern, often the perianal and perineal area of patients for treatment of IAD.

OBJECTIVE: Proposed utilization of a touch-free zinc oxide system (TFZO) to treat IAD in acute care patient population will demonstrate responsible use of resources, preservation of patient/caregiver dignity, and reduction of cross-contamination.

METHODS: A literature search was conducted to gather data for prevalence of IAD, average length of stay (LOS), and time to heal (TTH). Prevalence of IAD was 20% and 27%, respectively, in 2 acute care studies. Average LOS for IAD patients was found to be 5.5 to 7 days and TTH was 7 to 9 days. Average unit costs per product were included in the analysis and calculated for sample Hospital XYZ, a 250-bed acute care facility.

RESULTS: Using a computational model based on the literature review and data for prevalence, LOS and TTH costs were calculated, comparing application of TFZO treatment versus direct gloved application of zinc oxide ointment per group of patients (62.5) treated at an averaged prevalence rate of 25%. There was a range of realized cost reduction of $181.88 to $730.63 per week or $9457.50 to $37 992.50 over a 12-month period for Hospital XYZ. 

CONCLUSIONS: The TFZO application system is a unique example of how product presentation can be innovative in reducing health care costs. Accomplishment of cost savings, preserving patient dignity, reducing cross contamination risks, and reducing product waste should be encouraged when hospitals are seeking to provide quality care along with patient/caregiver satisfaction.

CITATION
Dick S, Tolentino AC. Economic model for cost containment: evaluating the utilization of a touch-free zinc oxide in an acute care hospital. Poster presented at: Symposium on Advanced Wound Care Fall; November 2-4, 2018; Las Vegas, NV.

Product: Touchless Care, Crawford Healthcare, Inc (Doylestown, PA)

This abstract was not subject to the WOUNDS peer-review process.